Would you buy stock in a company whose own scientists think the product might kill you?

The resignation of a former Anthropic employee raises serious concerns about the safety of AI technology, with insiders suggesting the risks could be life-threatening. This insider critique comes at a pivotal moment for AI companies, which are now under scrutiny for the potential dangers their innovations might pose. Investors are being forced to weigh the financial potential of these firms against the ethical implications of their products, questioning whether the benefits outweigh the risks. This situation underscores the urgent need for stricter regulations and more transparent risk assessments in the rapidly evolving AI sector.